Find and Join

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

• Education (and CE) from USP

  For the fourth year in a row, USP will be holding a hybrid live/virtual workshop dedicated to improving the quality of compounding. read more →

• Compounding post-Chevron

  At least three issues affecting pharmacy compounding might be affected by the overturning of the decades-old “Chevron doctrine.” read more →

• 503B sourcing: our state-by-state analysis

  Do you work for one of APC’s PFMs? If you’re with a Pharmacy/Facility Member, you’ve got access to a new resource. read more →

• What we’ll be talking about at CCH

  When we get together on Capitol Hill to meet with legislators and their staffs, as much as we’d like to talk about a half-dozen issues (easily!), we’re going to be focusing on the three most important.  read more →

More News

Twenty-five members of Congress signed a joint letter that was sent this week to FDA urging that the agency protect compounded hormone therapy and emphasizing the importance of continued patient access to compounded medications. The letter was anchored by Representative Jennifer Wexton (VA) and Representative Michael Burgess (TX). 

Other signers on the letter include: Mark E. Amodei (NV), Brian Babin, D.D.S. (TX), Stephanie Bice (OK), Jerry L. Carl (AL), Earl L. “ Buddy” Carter (GA), Kathy Castor (FL), Henry Cuellar (TX), Diana DeGette (CO), Mario Diaz-Balart (FL), Neal P. Dunn, M.D. (FL), Brian Fitzpatrick (PA), Diana Harshbarger (TN), Clay Higgins (LA), Debbie Lesko (AZ), Marianne Miller-Meeks (IA), John R. Moolenaar (MI), Gregory F. Murphy, M.D. (NC), Gary J. Palmer (AL), Jimmy Panetta (CA), Mark Pocan (WI), C.A. Dutch Ruppersberger (MD), Austin Scott (GA), and Robert J. Wittman (VA).

The APC board and staff are very appreciative of the support the above have shown on our behalf. We ask our members to take a moment to reach out and thank their respective MOCs. These things don’t just happen, and we need to express our appreciation when they do.

Want to help save compounded hormone therapy? Invest here. Find marketing tools you can use here. And send your patients and prescribers to compounding.com to learn more and share testimonials.